Related references
Note: Only part of the references are listed.Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
Geoffrey M. Lynn et al.
NATURE BIOTECHNOLOGY (2015)
Rational design of small molecules as vaccine adjuvants
Tom Y. -H. Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Harnessing the Power of the Immune System to Target Cancer
Gregory Lizee et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
John P. Vasilakos et al.
EXPERT REVIEW OF VACCINES (2013)
Polyinosinic-Polycytidylic Acid Is the Most Effective TLR Adjuvant for SIV Gag Protein-Induced T Cell Responses In Nonhuman Primates
Haesun Park et al.
JOURNAL OF IMMUNOLOGY (2013)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
HPMA copolymers: Origins, early developments, present, and future
Jindrich Kopecek et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Share Paper
